News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Mrinal M. Patnaik: Divergent effects of DNMT3A- and TET2-mutant clonal hematopoiesis in inflammatory response
Mrinal M. Patnaik/mayoclinic.org
Jan 27, 2025, 08:10

Mrinal M. Patnaik: Divergent effects of DNMT3A- and TET2-mutant clonal hematopoiesis in inflammatory response

Mrinal M. Patnaik, Physician Scientist, Department of Internal Medicine at Mayo Clinic, Minnesota, shared a recent article by him and colleagues on X:

“Single-cell multiomics reveal divergent effects of DNMT3A- and TET2-mutant clonal hematopoiesis in inflammatory response.

Why does DNMT3A CH increase mortality in the context of COVID-19 and VEXAS multiomics?”

“Single-cell multiomics reveal divergent effects of DNMT3A- and TET2-mutant clonal hematopoiesis in inflammatory response“

Authors: Wazim Mohammed Ismail, Jenna A. Fernandez, Moritz Binder, Terra L. Lasho, Minsuk Kim, Susan M. Geyer, Amelia Mazzone, Christy M. Finke, Abhishek A. Mangaonkar, Jeong-Heon Lee, Liguo Wang, Kwan Hyun Kim, Vernadette A. Simon, Fariborz Rakhshan Rohakthar, Amik Munankarmy, Seul Kee Byeon, Susan M. Schwager, Jonathan J. Harrington, Melissa R. Snyder, Keith D. Robertson, Akhilesh Pandey, Eric D. Wieben, Nicholas Chia, Alexandre Gaspar-Maia and Mrinal M. Patnaik

Mrinal M. Patnaik

More posts featuring Mrinal M. Patnaik.

Akhilesh Pandey Alexandre Gaspar-Maia cancer COVID19 Eric D. Wieben Hematopoiesis inflammatory response Jenna A. Fernandez Minsuk Kim Moritz Binder Mrinal M Patnaik Nicholas Chia OncoDaily Oncology Terra L Lasho Vexas Wazim Mohammed Ismail
Special Coverage
Blog
Apr 20, 2025, 16:48
Sendurai Mani: Wonderful visit to UNMC Genetics, Cell Biology and Anatomy seminar series
Science
Apr 20, 2025, 16:36
Moawia Mohammed Ali Elhassan: Ultrahypofractionated radiotherapy with SIB shows early safety in breast cancer
Science
Apr 20, 2025, 16:21
Shamir Geller: Our experience with JAK inhibitors in patients with cutaneous lymphoma
Insight
Apr 20, 2025, 16:05
Susanna Fletcher Greer: From weeds to warriors - how cancer’s helpers are becoming its worst enemy
Insight
Apr 20, 2025, 15:49
Raising a Glass or Raising the Risk? Rethinking Social Norms Around Alcohol: Sami Mansfield
Blog
Apr 20, 2025, 15:38
Larissa Nekhlyudov: Raising awareness about cancer survivorship in spring and early summer 2025
Science
Apr 20, 2025, 15:09
Vidith Phillips: AI is flooding healthcare journals, but which papers can you actually trust?
Blog
Apr 20, 2025, 14:56
Yan Leyfman: Promising results from CD19 CAR-NK Cell therapy trial
Blog
Apr 20, 2025, 14:41
Vun-Sin Lim: Vote for Alex Adjei for President-Elect in the 2025 IASLC Board of Directors election
Blog
Apr 20, 2025, 14:19
Michael Sapienza: Proud to welcome leaders and advocates to the 2025 Screen Smart Dinner
Blog
Apr 20, 2025, 14:07
Erika Hamilton: ESMO Breast Cancer 2025 is next month
Cancer Types
Apr 20, 2025, 13:50
Non-Small Cell Lung Cancer: Causes, Symptoms, Diagnosis, Treatment Options, and Latest 2025 Advances in Targeted and Immunotherapy